Asymchem Laboratories Tianjin Co (HKSE:06821) Change In Payables And Accrued Expense : HK$0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Asymchem Laboratories Tianjin Co Change In Payables And Accrued Expense?

Asymchem Laboratories Tianjin Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was HK$0 Mil. It means Asymchem Laboratories Tianjin Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

Asymchem Laboratories Tianjin Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was HK$0 Mil. It means Asymchem Laboratories Tianjin Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

Asymchem Laboratories Tianjin Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Asymchem Laboratories Tianjin Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asymchem Laboratories Tianjin Co Change In Payables And Accrued Expense Chart

Asymchem Laboratories Tianjin Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Asymchem Laboratories Tianjin Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Asymchem Laboratories Tianjin Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0 Mil.

Asymchem Laboratories Tianjin Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Asymchem Laboratories Tianjin Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Asymchem Laboratories Tianjin Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (HKSE:06821) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

7K90:Germany 002821:China

Address

No. 6 Dongting 3rd Street, Economic and Technological Development Zone, Tianjin, CHN, 300457

Website

https://www.asymchem.com

Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focuses on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.

Executives

Schroders Plc	2102 Investment manager
Citigroup Inc.	2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Norges Bank	2101 Beneficial owner
Barclays Plc	2201 Interest of corporation controlled by you
Fmr Llc	2201 Interest of corporation controlled by you
Fidelity Investment Trust	2101 Beneficial owner
Springhill Fund Asset Management (hk) Company Limited	2102 Investment manager
Springhill Fund Limited	2201 Interest of corporation controlled by you
Springhill Global Feeder Fund Limited	2201 Interest of corporation controlled by you
Springhill Master Fund Limited	2101 Beneficial owner
Morgan Stanley	2201 Interest of corporation controlled by you
Hhlr Advisors, Ltd.	2102 Investment manager
Hhlr Fund, L.p.	2101 Beneficial owner
Jpmorgan Asset Management (asia Pacific) Limited	2102 Investment manager

Asymchem Laboratories Tianjin Co Headlines

No Headlines